Patents by Inventor Mordechai Shohat

Mordechai Shohat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and kits for diagnosing and treating mental retardation
    Patent number: 7776551
    Abstract: The present invention provides methods, kits, isolated nucleic acid sequences, antibodies and addressable oligonucleotides microarrays which can be for analyzing sequence alterations and detecting the expression level of CC2D1A or nup62 in cells of an individual and thus diagnose nonsyndromic mental retardation (NSMR) and/or infantile bilateral striatal necrosis (IBSN) in the individual. In addition, the present invention provides methods and pharmaceutical compositions which can be used to treat pathologies associated with mental retardation such as NSMR or IBS.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: August 17, 2010
    Assignee: Ramot At Tel Aviv University Ltd.
    Inventors: Mordechai Shohat, Lina Basel
  • System, Method and Device for Comprehensive Individualized Genetic Information or Genetic Counseling
    Publication number: 20100094562
    Abstract: A method and system for analysis of genetic information. Preferably, such analysis enables genetic counseling to be provided to a patient and/or relative, in which such counseling includes conveying at least one aspect of the analysis in lay terms.
    Type: Application
    Filed: May 4, 2008
    Publication date: April 15, 2010
    Inventor: Mordechai Shohat
  • Methods and kits for diagnosing and treating mental retardation
    Publication number: 20070015194
    Abstract: The present invention provides methods, kits, isolated nucleic acid sequences, antibodies and addressable oligonucleotides microarrays which can be for analyzing sequence alterations and detecting the expression level of CC2D1A or nup62 in cells of an individual and thus diagnose nonsyndromic mental retardation (NSMR) and/or infantile bilateral striatal necrosis (IBSN) in the individual. In addition, the present invention provides methods and pharmaceutical compositions which can be used to treat pathologies associated with mental retardation such as NSMR or IBS.
    Type: Application
    Filed: July 12, 2006
    Publication date: January 18, 2007
    Inventors: Mordechai Shohat, Lina Basel